Claritev Corporation (CTEV) Stock
Claritev stock price chart
CTEV stock quote & key statistics
Claritev annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $965.4M | -$284.3M | -$16.81 |
| FY2024 | $930.6M | -$1.65B | -$47.01 |
| FY2023 | $961.5M | -$91.7M | -$4.03 |
| FY2022 | $1.08B | -$572.9M | $6.86 |
| FY2021 | $1.12B | $102.1M | $14.00 |
Fiscal year ending December 31. Source: company filings via EODHD.
About Claritev Corporation
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services.
It also provides data and analytics solutions consists of PlanOptix, CompleteVue, BenInsights, risk scores, and supplemental carrier services. The company provides solutions to commercial healthcare payers, third party administrators, employers, brokers/consultants, providers, government healthcare payers and system integrators. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, property and casualty insurers, bill review companies and other companies involved in the claims adjudication process.
The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in McLean, Virginia.
Claritev stock FAQ
What is the Claritev stock ticker symbol?
Claritev Corporation trades on the NYSE under the ticker symbol CTEV.
What sector and industry is Claritev in?
Claritev Corporation is classified in the Healthcare sector, Health Information Services industry.
How many employees does Claritev have?
Claritev Corporation has about 3,000 full-time employees.
What were Claritev's revenue and earnings last fiscal year?
Claritev reported revenue of $965.4M and net income of -$284.3M in fiscal 2025, with earnings per share of -$16.81. Revenue grew 3.7% from the prior year.
Is Claritev in the Russell 2000?
Yes. Claritev Corporation (CTEV) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.
When did Claritev go public?
Claritev stock began trading on April 3, 2020.
Russell 2000 Health Information Services stocks
All Russell 2000 →- BTSGBrightSpring Health Services
- CARLCarlsmed
- CERTCertara
- CYTKCytokinetics
- EVHEvolent Health
- GKOSGlaukos
- HNGEHinge Health
- HQYHealthEquity
- HSTMHealthStream
- HTFLHeartflow
- KRYSKrystal Biotech
- LFMDLifeMD
- NRCNational Research
- OMCLOmnicell
- OMDAOmada Health
- PCVXVaxcyte
- PHRPhreesia
- PRVAPrivia Health
- SDGRSchrödinger
- SPOKSpok
- TDOCTeladoc Health
- TWSTTwist Bioscience
- WAYWaystar
- WEAVWeave Communications